KOPRAN
Quarterly Results Analysis [Jun2025]
KOPRAN Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹135 Cr | ₹172 Cr | ₹166 Cr | ₹152 Cr | ₹139 Cr | ₹186 Cr | ₹159 Cr | ₹153 Cr |
Expenses | ₹121 Cr | ₹155 Cr | ₹146 Cr | ₹137 Cr | ₹121 Cr | ₹164 Cr | ₹135 Cr | ₹130 Cr |
Operating Income | ₹14 Cr | ₹17 Cr | ₹20 Cr | ₹15 Cr | ₹18 Cr | ₹22 Cr | ₹24 Cr | ₹23 Cr |
Other Income | ₹3 Cr | ₹3 Cr | ₹0 Cr | ₹1 Cr | ₹3 Cr | ₹10 Cr | ₹2 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹10 Cr | ₹14 Cr | ₹14 Cr | ₹10 Cr | ₹15 Cr | ₹25 Cr | ₹21 Cr | ₹18 Cr |
Profit After Tax | ₹7 Cr | ₹10 Cr | ₹10 Cr | ₹7 Cr | ₹11 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr |
EPS | ₹1.54 | ₹2.00 | ₹2.16 | ₹1.53 | ₹2.30 | ₹3.86 | ₹3.28 | ₹2.86 |
Industry Peers & Returns | 1W | 1M | 1Y |
KOPRAN | 0% | -10.8% | -34.4% |
SUN PHARMACEUTICAL INDUSTRIES | -1.9% | -4.1% | -6.6% |
DIVIS LABORATORIES | -3.6% | -12.3% | 27.1% |
CIPLA | -0.7% | -0% | -2.9% |
TORRENT PHARMACEUTICALS | -2.1% | 7.2% | 9.3% |
DR REDDYS LABORATORIES | -1.6% | -5.4% | -12.1% |
MANKIND PHARMA | -0.8% | 0.7% | 25.8% |
ZYDUS LIFESCIENCES | -0.4% | -3.4% | -23.9% |
LUPIN | 4.3% | 1.7% | -2.9% |
KOPRAN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -21.55 % |
Y-o-Y | -3.03 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹135 Cr | -21.55 | |
Mar2025 | ₹172 Cr | 3.68 | |
Dec2024 | ₹166 Cr | 9.69 | |
Sep2024 | ₹152 Cr | 8.70 | |
Jun2024 | ₹139 Cr | -25.07 | |
Mar2024 | ₹186 Cr | 17.09 | |
Dec2023 | ₹159 Cr | 4.15 | |
Sep2023 | ₹153 Cr | - |
KOPRAN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -17.31 % |
Y-o-Y | -22.20 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹14 Cr | -17.31 | |
Mar2025 | ₹17 Cr | -13.87 | |
Dec2024 | ₹20 Cr | 34.60 | |
Sep2024 | ₹15 Cr | -18.85 | |
Jun2024 | ₹18 Cr | -16.27 | |
Mar2024 | ₹22 Cr | -8.01 | |
Dec2023 | ₹24 Cr | 3.31 | |
Sep2023 | ₹23 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 5.45 % |
Y-o-Y | -19.80 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 10.45% | 5.45 | |
Mar2025 | 9.91% | -16.93 | |
Dec2024 | 11.93% | 22.74 | |
Sep2024 | 9.72% | -25.40 | |
Jun2024 | 13.03% | 11.75 | |
Mar2024 | 11.66% | -21.43 | |
Dec2023 | 14.84% | -0.80 | |
Sep2023 | 14.96% | - |
KOPRAN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -23.02 % |
Y-o-Y | -32.85 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹7 Cr | -23.02 | |
Mar2025 | ₹10 Cr | -6.89 | |
Dec2024 | ₹10 Cr | 40.76 | |
Sep2024 | ₹7 Cr | -33.44 | |
Jun2024 | ₹11 Cr | -40.42 | |
Mar2024 | ₹19 Cr | 17.90 | |
Dec2023 | ₹16 Cr | 14.70 | |
Sep2023 | ₹14 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -1.78 % |
Y-o-Y | -30.78 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 5.51 % | -1.78 | |
Mar2025 | 5.61 % | -10.24 | |
Dec2024 | 6.25 % | 28.34 | |
Sep2024 | 4.87 % | -38.82 | |
Jun2024 | 7.96 % | -20.48 | |
Mar2024 | 10.01 % | 0.70 | |
Dec2023 | 9.94 % | 10.20 | |
Sep2023 | 9.02 % | - |
KOPRAN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -23.00 % |
Y-o-Y | -33.04 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹1.54 | -23.00 | |
Mar2025 | ₹2 | -7.41 | |
Dec2024 | ₹2.16 | 41.18 | |
Sep2024 | ₹1.53 | -33.48 | |
Jun2024 | ₹2.3 | -40.41 | |
Mar2024 | ₹3.86 | 17.68 | |
Dec2023 | ₹3.28 | 14.69 | |
Sep2023 | ₹2.86 | - |
You may also like the below Video Courses